Login
Login

Tag: Untitled Letter

CHC_DTCadvertisement2

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

Learn More
socialmedia.news (1)

OPDP Cites Lilly for Omission of Risk Info in Trulicity Instagram Post

Learn More
CHC_DTCadvertisement2

OPDP, Lilly Come to Terms Over TV Ads for Migraine Drug

Learn More
FDA-News (1)

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

Learn More
fda-logo

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery

Learn More
CHC_DTCadvertisement2

Two Recent OPDP Letters Prompted by “Bad Ad Program” Complaints

Learn More
fda-logo

Azurity Email Garners OPDP Enforcement Letter for False/Misleading Claims

Learn More
CHC_DTCadvertisement2

OPDP Cites Xeris for Risk Presentation Issues in DTC TV Ad

Learn More
CHC_FDA-Regulatory Images1

Press Release Highlighting Omission of Risk Warning Letter Closes OPDP’s Enforcement Year

Learn More